Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810Appleman, Leonard J ; Kim, Se Eun ; Harris, Wayne B ; Pal, Sumanta K ; Pins, Michael R ; Kolesar, Jill ; Agarwal, Neeraj ; Parikh, Rahul A ; Vaena, Daniel A ; Ryan, Christopher W ; Hashmi, Mehmood ; Costello, Brian A ; Cella, David ; Dutcher, Janice P ; DiPaola, Robert S ; Haas, Naomi B ; Wagner, Lynne I ; Carducci, Michael AJournal of clinical oncology, 2024-06, Vol.42 (17), p.2061-2070 [Periódico revisado por pares]Sem texto completo |
|
2 |
Material Type: Artigo
|
Epidemiologic Methods to Advance Our Understanding of Ovarian Cancer RiskHarris, Holly R ; Davis, Colette P ; Terry, Kathryn LJournal of clinical oncology, 2024-05, p.JCO2400602-JCO2400602 [Periódico revisado por pares]United StatesSem texto completo |
|
3 |
Material Type: Artigo
|
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810Appleman, Leonard J ; Kim, Se Eun ; Harris, Wayne B ; Pal, Sumanta K ; Pins, Michael R ; Kolesar, Jill ; Agarwal, Neeraj ; Parikh, Rahul A ; Vaena, Daniel A ; Ryan, Christopher W ; Hashmi, Mehmood ; Costello, Brian A ; Cella, David ; Dutcher, Janice P ; DiPaola, Robert S ; Haas, Naomi B ; Wagner, Lynne I ; Carducci, Michael AJournal of clinical oncology, 2024-03, p.JCO2301544 [Periódico revisado por pares]United StatesSem texto completo |
|
4 |
Material Type: Artigo
|
The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General MeasureCella, D F ; Tulsky, D S ; Gray, G ; Sarafian, B ; Linn, E ; Bonomi, A ; Silberman, M ; Yellen, S B ; Winicour, P ; Brannon, JJournal of clinical oncology, 2023-12, Vol.41 (35), p.5335-5344 [Periódico revisado por pares]United StatesSem texto completo |
|
5 |
Material Type: Artigo
|
Phase 1 first-in-human study of PF-07257876, a novel CD47/PD-L1 bispecific checkpoint inhibitor, in patients with PD-1/PD-L1-refractory and -naïve advanced solid tumorsCarneiro, Benedito A. ; Safran, Howard ; Beck, J. Thaddeus Thaddeus ; Hamid, Omid ; Spira, Alexander I. ; Savvides, Panos ; Gutierrez, Martin ; Zhao, Yujie ; Abbruzzese, James L. ; Ward, Jeffrey P. ; Weroha, Saravut John ; Harris, Loleta D. ; Kent, Sean ; Pierceall, William ; Skoura, Athanasia ; Zheng, Jenny ; Kern, Kenneth Alan ; Thomas, Jacob Stephen ; Santana-Davila, RafaelJournal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2529-2529 [Periódico revisado por pares]Texto completo disponível |
|
6 |
Material Type: Artigo
|
NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, HR+, HER2-, RS ≤18 breast cancerWhite, Julia R. ; Cecchini, Reena S. ; Harris, Eleanor Elizabeth ; Mamounas, Eleftherios P. ; Stover, Daniel G. ; Ganz, Patricia A. ; Jagsi, Reshma ; Anderson, Stewart J. ; Bergom, Carmen ; Theberge, Valerie ; El-Tamer, Mahmoud ; Zellars, Richard C. ; Shumway, Dean Alden ; Chen, Guang-Pei ; Julian, Thomas B. ; Wolmark, Norman ; Goodwin, AnnabelJournal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS623-TPS623 [Periódico revisado por pares]Texto completo disponível |
|
7 |
Material Type: Artigo
|
Blood-based assessment of patients with mismatch repair-deficient tumors enrolled in NCI-MATCH Arm Z1D (nivolumab)Karlovich, Chris Alan ; Silhavy, Jennifer ; LoCoco, Jennifer S. ; Das, Biswajit ; Rahmanian, Sorena ; Chang, Ting-Chia ; Peach, Amanda ; Harrington, Robin ; Chen, Li ; Harris, Lyndsay ; Fu, Yao ; Patton, David R. ; Li, Jessica ; Chen, Alice P. ; Takebe, Naoko ; Pawlowski, Traci L. ; McShane, Lisa ; Febbo, Phillip G. ; Doroshow, James H. ; Williams, P. MickeyJournal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2560-2560 [Periódico revisado por pares]Texto completo disponível |
|
8 |
Material Type: Artigo
|
Phase II study of crizotinib in patients with MET amplification and MET exon 14 deletion: Results from NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocols C1 and C2Coleman, Niamh ; Wei, Zihan ; Hong, David S. ; Mitchell, Edith P. ; Zwiebel, James A. ; Sharon, Elad ; Gray, Robert James ; Wang, Victoria ; McShane, Lisa ; Rubinstein, Larry V. ; Patton, David R. ; Williams, P. Mickey ; Tricoli, James V. ; Conley, Barbara A. ; Arteaga, Carlos L. ; Harris, Lyndsay ; O'Dwyer, Peter J. ; Chen, Alice P. ; Flaherty, Keith ; Hamilton, Stanley R.Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3108-3108 [Periódico revisado por pares]Texto completo disponível |
|
9 |
Material Type: Artigo
|
Molecular profiling of ctDNA from NCI-MATCH patients enrolled for treatment with mTOR1/2 inhibitor sapanisertib (arm M) and the Hedgehog pathway inhibitor vismodegib (arm T)LoCoco, Jennifer S. ; Das, Biswajit ; Rahmanian, Sorena ; Chang, Ting-Chia ; Silhavy, Jennifer ; Chen, Li ; Harrington, Robin ; Peach, Amanda ; Fu, Yao ; McShane, Lisa ; Li, Jessica ; Chen, Alice P. ; Takebe, Naoko ; Harris, Lyndsay ; Patton, David R. ; Pawlowski, Traci L. ; Febbo, Phillip G. ; Doroshow, James H. ; Williams, P. Mickey ; Karlovich, Chris AlanJournal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3047-3047 [Periódico revisado por pares]Texto completo disponível |
|
10 |
Material Type: Artigo
|
The EPOCH trial: Identifying key patient subgroups to optimize treatment planningHarris, William P. ; Salem, RiadJournal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.130-130 [Periódico revisado por pares]Texto completo disponível |